On August 26, 2019 Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, reported the company will participate at the upcoming 17th Annual Morgan Stanley Global Healthcare Conference being held from September 9-11, 2019 in New York, NY (Press release, Personalis, AUG 26, 2019, View Source [SID1234538977]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Personalis is scheduled to participate in a fireside chat with analysts and investors on Wednesday, September 11, 2019 at 1:00 p.m. Eastern Time. A live, listen-only webcast of the presentation may be accessed by visiting investors.personalis.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company’s website for 180 days following the presentation.